NCT04006184

Brief Summary

This study is a retrospective, chart review of treatment of patients with symptomatic varicose veins. Treated limbs must have the Great Saphenous Vein and/or Small Saphenous Vein treated with either cyanoacrylate closure (VenaSeal) or Endothermal Ablation (either Radiofrequency Ablation or Endovenous Laser Ablation).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
547

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 14, 2019

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

June 29, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 5, 2019

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2019

Completed
Last Updated

October 3, 2019

Status Verified

October 1, 2019

Enrollment Period

2 months

First QC Date

June 29, 2019

Last Update Submit

October 1, 2019

Conditions

Keywords

VenasealSymptomatic Varicose Veins

Outcome Measures

Primary Outcomes (2)

  • Adjunctive phlebectomy

    Compare need for/utilization of adjunctive phlebectomy performed as a concomitant or staged procedure

    Through 6 months of index procedure

  • Cost of Treatment

    A cost analysis will be performed calculating the total cost of treatment between groups

    Through six months of index procedure

Secondary Outcomes (4)

  • Severity of Disease

    At treatment through six months of index procedure

  • Severity of Disease

    At treatment through six months of index procedure

  • Utilization of adjunctive treatments

    Through six months of index procedure

  • Adverse events reported during clinic visits

    Though six months of index procedure

Study Arms (2)

Endovenous Thermal Ablation

Limbs treated with either radiofrequency ablation or endovenous laser ablation

Other: Chart review

Cyanoacrylate Closure

Limbs treated with cyanoacrylate closure system

Other: Chart review

Interventions

Retrospective review of medical records at a single site with six physicians

Cyanoacrylate ClosureEndovenous Thermal Ablation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

327 limbs treated with Cyanoacrylate Closure and 327 limbs treated with Endovenous Thermal Ablation for symptomatic varicose veins and incompetence of the great or small saphenous vein, or both veins.

You may qualify if:

  • Limb with saphenous vein incompetence, treated with one of the following:
  • VenaSeal â„¢ Endovenous Laser Ablation Radiofrequency Ablation
  • CEAP Clinical Class between 2-5
  • Limb treated from October 1st, 2015-present
  • At least 2 months of follow-up post index procedure
  • Treatment of either the great saphenous vein (GSV), the small saphenous vein (SSV), or both. Treatment of accessory saphenous veins (ASV) is allowed as long as either the GSV, SSV, or both the GSV and SSV were treated as well in that limb at the index procedure.

You may not qualify if:

  • Limb treatment of the accessory saphenous vein (ASV) without concomitant great saphenous vein (GSV) and/or small saphenous vein (SSV) treatment
  • Limb treatment for reasons other than symptomatic varicose veins
  • Limbs without follow-up information at least 2 months following the index procedure
  • Subjects who participated in another clinical trial as part of their saphenous vein treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lake Washington Vascular, PLLC

Bellevue, Washington, 98004, United States

Location

MeSH Terms

Conditions

Varicose VeinsVenous Insufficiency

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Kathleen D Gibson, MD

    Lake Washington Vascular, PLLC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2019

First Posted

July 5, 2019

Study Start

June 14, 2019

Primary Completion

July 30, 2019

Study Completion

August 30, 2019

Last Updated

October 3, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations